-
The market is taking its first proactive steps to resolve issues posed by the massive systemic exposures it is running. -
RenaissanceRe has always been a business with strong convictions and an assured management team, willing to carve out a path distinct from competitors.
-
PE firms still hungry for insurance investment are looking further afield than the UK and the US – but international aggregation is a different game.
-
After a half-year update on the Blueprint Two programme, Insurance Insider explores what has been delivered, but also the questions on how adoption will play out.
-
As the Treasury falls under pressure to ramp up oversight of the FCA and PRA, Insurance Insider explores what this should mean in practice.
-
A long-awaited return to international travel lies ahead, but do executives – and their expense accounts – still have the stamina for it?
-
The biggest challenge with reporting on the legacy market is the lack of publicly available information to track the sector’s performance.
-
Arguably the Corporation could find more creative ways to promote its ESG targets, but the reality is that the showy protests are of less relevance than winning boardroom votes.
-
If you believe that the Lloyd's market has turned around its fortunes, it’s a buyers’ market on Lime Street.
-
There is much to like in the transaction, but a strategy based on serial mega deals elevates the group’s risk profile.
-
The carrier’s move to cement its identity as a specialty (re)insurer could put it at a competitive disadvantage.
-
Reinsurers are still limiting exposure to the market despite securing major concessions, and Citizens’ buying tactics highlight the gulf between buyers and sellers.
